Dental supply maker Patterson Companies Inc (NASDAQ:PDCO) announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.
What Happened: The company disclosed the sale process as part of its second-quarter financial report.
Earnings were mixed, “given the challenging end market environment,” said Patterson CEO Don Zurbay.
Patterson posted second-quarter 2025 net sales of $1.67 billion. That’s up 1.3% year-over-year. Wall Street expected a net sales of $1.65 billion. Internal sales increased just 0.6%.
Here’s a breakdown of the dental business:
As for Patterson’s animal health segment:
The company reported adjusted EPS of 47 cents. That’s down from 50 cents a year ago. It missed the consensus of 49 cents.
GAAP and adjusted earnings were also negatively impacted by the Change Healthcare cyber attack.
Patterson “took dedicated cost management actions” and “made targeted investments in complementary businesses,” according to Zurbay.
Outlook: Patterson expects fiscal year 2025 adjusted EPS Of $2.25-$2.35 compared to the consensus of $2.32 and prior guidance of $2.33-$2.43.
Price Action: Patterson stock is up 6.54% at $23.31 during the premarket session at last check Thursday.
Read Next:
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.